Publications

Elespuru RK, Agarwal R, Atrakchi A, Bigger CAH, Heflich RH, Jagannath D, Levy DD…Robison TW, et al. 2009. Current and future application of genetic toxicity assays: The role and value of in vitro mammalian assays. Toxicol Sci 109(2):172-179; doi: 10.1093/toxsci/kfp067.

Covington TR, Jakubowski EM, McGuire JM, Evans RA, Hulet SW, Gearhart JM. Accounting for stereo-isomers and ionization in a PBPK/PD model of VX exposure. Poster presented at the Society of Toxicology Annual Meeting, Baltimore, MD, March 2009.

Gatto N, Kelsh M, HaMai D, Suh M, Proctor D. A meta-analysis of the relationship between occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract. Society of Toxicology 48th Annual Meeting, Baltimore, MD, March 2009.

Staskal DF, Birnbaum LS. Screening-level assessment of risk associated with exposure to PBDEs in vehicles. Society for Toxicology 48^th Annual Meeting, Baltimore, MD, March 2009.

Wheeler MW, Bailer AJ. 2009. Comparing model averaging with other model selection strategies for benchmark dose estimation. Environ Ecol Stat 16:37-51; doi: 10.1007/s10651-007-0071-7.

Urban JD, Tachovsky JA, Staskal DF, Haws LC, Harris MA. Human health risk assessment of consumption of fish from the Lower Passaic River. Presented Society for Toxicology 48th Annual Meeting, Baltimore, MD, March 2009.

Enright BP, Compton DR, Collins N, Davis T, McIntyre BS. 2009. Comparative effects of interferon alpha-2b and pegylated interferon alpha-2b on menstrual cycles and ovarian hormones in Cynomolgus monkeys. Birth Defects Res B 86(1):29–39; doi: 10.1002/bdrb.20179. PMID: 19243028.

Wheeler MW, Bailer AJ. 2009. Benchmark dose estimation incorporating multiple data sources. Risk Anal 29(2):249-56; doi: 10.1111/j.1539-6924.2008.01144x. PMID: 19000080.

Sacks NC. 2009. Healthcare spending among privately insured individuals under age 65. IMS Health, February.

Thompson CM, Johns DO, Sonawane S, Barton HA, Hattis D, Tardif R, Krishnan K. 2009. Database for physiologically based pharmacokinetic (PBPK) modeling: Physiological parameters for healthy and health-impaired elderly. J Toxicol Environ Health B 12(1):1–24; doi: 10.1080/10937400802545060. PMID: 19117207.

Clewell RA, Kremer JJ, Williams CC, Campbell JL, Sochaski MA, Andersen ME, Borghoff SJ. 2009. Kinetics of selected di-n-butyl phthalate metabolites and fetal testosterone following repeated and single administration in pregnant rats. Toxicology 255(1–2):80–90; doi: 10.1016/j.tox.2008.10.010. PMID: 19010379.

Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.

Luo W, Nordstrom BL, Fraeman K, Nordyke RJ, Ranganathan G, Linz HE, Winterkorn A, Stokes M, et al. 2008. Adherence to guidelines for use of ESAs in patients with chemotherapy-induced anemia: Results of a retrospective study of an EMR database in the US, 2002-2006. Clin Ther 30(12):2423-35; doi: 10.1016/j.clinthera.2008.12.022. PMID: 19167601.

Makris SL, Thompson CM, Euling SY, Selevan SG, Sonawane B. 2008. A lifestage-specific approach to hazard and dose-response characterization for children’s health risk assessment. Birth Defects Res B 83(6):530–546; doi: 10.1002/bdrb.20176. PMID: 19085945.

Thompson CM, Subramaniam RP, Grafström RC. 2008. Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. Toxicol Appl Pharmacol 233(3):355–359; doi: 10.1016/j.taap.2008.09.011. PMID: 18851987.

Wagner ME, Travis LB. 2008. Letter to the editor re: “Mesothelioma and asbestos.” Regul Toxicol Pharmacol 52(3):353–354 (author reply, 355); doi: 10.1016/j.yrtph.2008.07.001. PMID: 18680780.

Proctor D. 2008. Hexavalent chromium. In: Encyclopedia of Quantiative Risk Analysis and Assessment, Melnick E, Everitt B. (eds.). Wiley.

Harris MA, Shay E, Unice KM, Scott LF, Haws LC. Preliminary evaluation of health risks posed by PCDD/Fs and PCBs from the ingestion of fish from the Lower Passaic River. Presented at Dioxin 2008, Birmingham, England, August 2008.

Covington TR, Gearhart JM, Jakubowski EM, McGuire JM, Evans RA, Hulet SW. Physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling of VX exposure through various routes to multiple species. Poster presented at the Chemical and Biological Defense Physical Science and Technology Conference, New Orleans, LA, November 2008.

Garabrant DH, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, et al. 2008. Factors that predict serum PCB, PCDD, and PCDF concentrations in Michigan, USA. Epidemiology 19(6):S265; doi: 10.1097/01.ede.0000340275.84909.26.